XNK Therapeutics to present at the 8th CAR-TCR Summit in Boston
XNK Therapeutics AB (“XNK”) today announced that Linda Brick, Head of QA, will be speaking at the 8th CAR-TCR Summit in Boston.The annual CAR-TCR Summit is the world’s pre-eminent industry-leading comprehensive forum that unites the global cell therapy community across a variety of cell types (αβ T, γδ T, NK, NKT, Macrophage, TIL and more), Over 1000 experts from both pharmaceutical companies, including autologous and allogeneic cell therapy drug developers, and academia participate to advance the field.
On August 30, Linda Brink will present XNK and talk about improving training and